308 related articles for article (PubMed ID: 26284765)
1. Pancreatitis Secondary to Anti-Programmed Death Receptor 1 Immunotherapy Diagnosed by FDG PET/CT.
Alabed YZ; Aghayev A; Sakellis C; Van den Abbeele AD
Clin Nucl Med; 2015 Nov; 40(11):e528-9. PubMed ID: 26284765
[TBL] [Abstract][Full Text] [Related]
2. Immune-mediated Disease in Ipilimumab Immunotherapy of Melanoma with FDG PET-CT.
Wachsmann JW; Ganti R; Peng F
Acad Radiol; 2017 Jan; 24(1):111-115. PubMed ID: 27818005
[TBL] [Abstract][Full Text] [Related]
3. Ipilimumab-induced hepatitis on 18F-FDG PET/CT in a patient with malignant melanoma.
Raad RA; Pavlick A; Kannan R; Friedman KP
Clin Nucl Med; 2015 Mar; 40(3):258-9. PubMed ID: 25290291
[TBL] [Abstract][Full Text] [Related]
4. 18F-FDG PET/CT Reveals Disease Remission in a Patient With Ipilimumab-Refractory Advanced Melanoma Treated With Pembrolizumab.
Sachpekidis C; Hassel JC; Dimitrakopoulou-Strauss A
Clin Nucl Med; 2016 Feb; 41(2):156-8. PubMed ID: 26545022
[TBL] [Abstract][Full Text] [Related]
5. Ipilimumab-induced colitis on FDG PET/CT.
Lyall A; Vargas HA; Carvajal RD; Ulaner G
Clin Nucl Med; 2012 Jun; 37(6):629-30. PubMed ID: 22614208
[TBL] [Abstract][Full Text] [Related]
6. Radiographic Profiling of Immune-Related Adverse Events in Advanced Melanoma Patients Treated with Ipilimumab.
Tirumani SH; Ramaiya NH; Keraliya A; Bailey ND; Ott PA; Hodi FS; Nishino M
Cancer Immunol Res; 2015 Oct; 3(10):1185-92. PubMed ID: 26100356
[TBL] [Abstract][Full Text] [Related]
7. Focal Immunotherapy-Induced Pancreatitis Mimicking Metastasis on FDG PET/CT.
Das JP; Halpenny D; Do RK; Ulaner GA
Clin Nucl Med; 2019 Oct; 44(10):836-837. PubMed ID: 31283599
[TBL] [Abstract][Full Text] [Related]
8. Predictive value of early 18F-FDG PET/CT studies for treatment response evaluation to ipilimumab in metastatic melanoma: preliminary results of an ongoing study.
Sachpekidis C; Larribere L; Pan L; Haberkorn U; Dimitrakopoulou-Strauss A; Hassel JC
Eur J Nucl Med Mol Imaging; 2015 Mar; 42(3):386-96. PubMed ID: 25359635
[TBL] [Abstract][Full Text] [Related]
9. Isolated recto-sigmoid colitis: a new imaging pattern of ipilimumab-associated colitis.
Barina AR; Bashir MR; Howard BA; Hanks BA; Salama AK; Jaffe TA
Abdom Radiol (NY); 2016 Feb; 41(2):207-14. PubMed ID: 26867901
[TBL] [Abstract][Full Text] [Related]
10. Ipilimumab-Induced Adrenalitis: A Possible Pitfall in 18F-FDG-PET/CT.
Bacanovic S; Burger IA; Stolzmann P; Hafner J; Huellner MW
Clin Nucl Med; 2015 Nov; 40(11):e518-9. PubMed ID: 26164177
[TBL] [Abstract][Full Text] [Related]
11. Detection of early onset of hypophysitis by (18)F-FDG PET-CT in a patient with advanced stage melanoma treated with ipilimumab.
van der Hiel B; Blank CU; Haanen JB; Stokkel MP
Clin Nucl Med; 2013 Apr; 38(4):e182-4. PubMed ID: 23455528
[TBL] [Abstract][Full Text] [Related]
12. Imaging findings of immune checkpoint inhibitor associated pancreatitis.
Das JP; Postow MA; Friedman CF; Do RK; Halpenny DF
Eur J Radiol; 2020 Oct; 131():109250. PubMed ID: 32905952
[TBL] [Abstract][Full Text] [Related]
13. (18)F-FDG PET/CT and Melanoma: Staging, Immune Modulation and Mutation-Targeted Therapy Assessment, and Prognosis.
Perng P; Marcus C; Subramaniam RM
AJR Am J Roentgenol; 2015 Aug; 205(2):259-70. PubMed ID: 26204273
[TBL] [Abstract][Full Text] [Related]
14. [Stable disease or complete response? : A critical evaluation of the radiologic response to immune checkpoint blockade in advanced melanoma].
Tietze JK; Heppt M; Angelova D; Ruzicka T; Berger F; Berking C
Hautarzt; 2017 Aug; 68(8):632-638. PubMed ID: 28382381
[TBL] [Abstract][Full Text] [Related]
15. Autoimmune pancreatitis after nivolumab anti-programmed death receptor-1 treatment.
Dehghani L; Mikail N; Kramkimel N; Soyer P; Lebtahi R; Mallone R; Larger E
Eur J Cancer; 2018 Nov; 104():243-246. PubMed ID: 30454710
[No Abstract] [Full Text] [Related]
16. Regorafenib-Associated Acute Pancreatitis Diagnosed on 18F-FDG PET/CT.
Pereira M; Prakash A; Puranik AD; Purandare N; Shah S; Agrawal A; Rangarajan V
Clin Nucl Med; 2021 May; 46(5):e256-e257. PubMed ID: 33315679
[TBL] [Abstract][Full Text] [Related]
17. Ipilimumab-induced immunomediated adverse events: possible pitfalls in (18)F-FDG PET/CT interpretation.
Gilardi L; Colandrea M; Vassallo S; Travaini LL; Paganelli G
Clin Nucl Med; 2014 May; 39(5):472-4. PubMed ID: 23640225
[TBL] [Abstract][Full Text] [Related]
18. Pancreatic Cancer Complicated by Pancreatitis Demonstrated on FDG PET/CT.
Hennessy G; Vamadevan S; Loh H; Bui C; Le K; Mansberg R
Clin Nucl Med; 2017 Mar; 42(3):239-240. PubMed ID: 28098664
[TBL] [Abstract][Full Text] [Related]
19. Anti-CTLA4 antibody therapy related complications on FDG PET/CT.
Koo PJ; Klingensmith WC; Lewis KD; Bagrosky BM; Gonzalez R
Clin Nucl Med; 2014 Jan; 39(1):e93-6. PubMed ID: 23657138
[TBL] [Abstract][Full Text] [Related]
20. Management of Adverse Events Following Treatment With Anti-Programmed Death-1 Agents.
Weber JS; Postow M; Lao CD; Schadendorf D
Oncologist; 2016 Oct; 21(10):1230-1240. PubMed ID: 27401894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
